Prof. Dr. Ross L. Levine has been Chair of QIAGEN’s Scientific Advisory Board since 2021, and also served as a member of the Supervisory Board from 2016-2026. A physician-scientist focused on researching and treating blood and bone-marrow cancers, Dr. Levine is the Chief Scientific Officer and the Edward P. Evans Endowed Chair for Myelodysplastic Syndromes at Memorial Sloan Kettering Cancer Center in New York. He is board-certified in internal medicine and hematology-oncology and received a bachelor’s degree from Harvard College and his medical degree from the Johns Hopkins University School of Medicine.